nodes	percent_of_prediction	percent_of_DWPC	metapath
Norepinephrine—ADRA2C—attention deficit hyperactivity disorder	0.438	0.571	CbGaD
Norepinephrine—ADRA2A—attention deficit hyperactivity disorder	0.187	0.244	CbGaD
Norepinephrine—DRD2—attention deficit hyperactivity disorder	0.142	0.185	CbGaD
Norepinephrine—SLC6A2—locus ceruleus—attention deficit hyperactivity disorder	0.00654	0.117	CbGeAlD
Norepinephrine—POU5F1—cerebellum—attention deficit hyperactivity disorder	0.00573	0.102	CbGeAlD
Norepinephrine—SLC6A2—autonomic nervous system—attention deficit hyperactivity disorder	0.00347	0.062	CbGeAlD
Norepinephrine—SLC18A1—nervous system—attention deficit hyperactivity disorder	0.00225	0.0402	CbGeAlD
Norepinephrine—SLC18A1—central nervous system—attention deficit hyperactivity disorder	0.00217	0.0387	CbGeAlD
Norepinephrine—SLC18A1—brain—attention deficit hyperactivity disorder	0.00172	0.0307	CbGeAlD
Norepinephrine—PAH—nervous system—attention deficit hyperactivity disorder	0.00162	0.0289	CbGeAlD
Norepinephrine—PAH—central nervous system—attention deficit hyperactivity disorder	0.00156	0.0278	CbGeAlD
Norepinephrine—SLC18A2—forebrain—attention deficit hyperactivity disorder	0.00133	0.0237	CbGeAlD
Norepinephrine—ADRA1D—forebrain—attention deficit hyperactivity disorder	0.00131	0.0234	CbGeAlD
Norepinephrine—PAH—brain—attention deficit hyperactivity disorder	0.00124	0.0221	CbGeAlD
Norepinephrine—SLC22A1—forebrain—attention deficit hyperactivity disorder	0.000989	0.0176	CbGeAlD
Norepinephrine—ADRB1—forebrain—attention deficit hyperactivity disorder	0.000952	0.017	CbGeAlD
Norepinephrine—SLC18A2—midbrain—attention deficit hyperactivity disorder	0.000876	0.0156	CbGeAlD
Norepinephrine—Levonordefrin—ADRA2C—attention deficit hyperactivity disorder	0.000817	0.107	CrCbGaD
Norepinephrine—SLC6A2—forebrain—attention deficit hyperactivity disorder	0.00081	0.0144	CbGeAlD
Norepinephrine—ADRB1—cardiovascular system—attention deficit hyperactivity disorder	0.000805	0.0144	CbGeAlD
Norepinephrine—ADRA1A—forebrain—attention deficit hyperactivity disorder	0.000753	0.0134	CbGeAlD
Norepinephrine—DRD2—forebrain—attention deficit hyperactivity disorder	0.000738	0.0132	CbGeAlD
Norepinephrine—ADRA1B—nervous system—attention deficit hyperactivity disorder	0.000727	0.013	CbGeAlD
Norepinephrine—SLC18A2—nervous system—attention deficit hyperactivity disorder	0.00072	0.0128	CbGeAlD
Norepinephrine—ADRA1D—nervous system—attention deficit hyperactivity disorder	0.000712	0.0127	CbGeAlD
Norepinephrine—ADRA1B—central nervous system—attention deficit hyperactivity disorder	0.0007	0.0125	CbGeAlD
Norepinephrine—SLC18A2—central nervous system—attention deficit hyperactivity disorder	0.000694	0.0124	CbGeAlD
Norepinephrine—ADRA1D—central nervous system—attention deficit hyperactivity disorder	0.000685	0.0122	CbGeAlD
Norepinephrine—SLC18A2—cerebellum—attention deficit hyperactivity disorder	0.000678	0.0121	CbGeAlD
Norepinephrine—ADRA1A—cardiovascular system—attention deficit hyperactivity disorder	0.000637	0.0114	CbGeAlD
Norepinephrine—Methyldopa—COMT—attention deficit hyperactivity disorder	0.000617	0.0808	CrCbGaD
Norepinephrine—Droxidopa—ADRA2C—attention deficit hyperactivity disorder	0.000576	0.0753	CrCbGaD
Norepinephrine—ADRA2A—forebrain—attention deficit hyperactivity disorder	0.000572	0.0102	CbGeAlD
Norepinephrine—ADRA1B—brain—attention deficit hyperactivity disorder	0.000556	0.00991	CbGeAlD
Norepinephrine—SLC18A2—brain—attention deficit hyperactivity disorder	0.000551	0.00982	CbGeAlD
Norepinephrine—ADRA1D—brain—attention deficit hyperactivity disorder	0.000544	0.0097	CbGeAlD
Norepinephrine—SLC22A1—nervous system—attention deficit hyperactivity disorder	0.000537	0.00957	CbGeAlD
Norepinephrine—ADRB1—nervous system—attention deficit hyperactivity disorder	0.000517	0.00922	CbGeAlD
Norepinephrine—SLC22A1—central nervous system—attention deficit hyperactivity disorder	0.000517	0.00921	CbGeAlD
Norepinephrine—L-DOPA—DRD5—attention deficit hyperactivity disorder	0.000514	0.0672	CrCbGaD
Norepinephrine—SLC22A3—nervous system—attention deficit hyperactivity disorder	0.000513	0.00915	CbGeAlD
Norepinephrine—ADRB1—central nervous system—attention deficit hyperactivity disorder	0.000498	0.00887	CbGeAlD
Norepinephrine—SLC22A3—central nervous system—attention deficit hyperactivity disorder	0.000494	0.00881	CbGeAlD
Norepinephrine—DRD2—midbrain—attention deficit hyperactivity disorder	0.000487	0.00869	CbGeAlD
Norepinephrine—Phenylephrine—MAOA—attention deficit hyperactivity disorder	0.000478	0.0625	CrCbGaD
Norepinephrine—Dopamine—DRD5—attention deficit hyperactivity disorder	0.000478	0.0625	CrCbGaD
Norepinephrine—ADRA2C—midbrain—attention deficit hyperactivity disorder	0.000474	0.00845	CbGeAlD
Norepinephrine—SLC22A5—midbrain—attention deficit hyperactivity disorder	0.000454	0.00809	CbGeAlD
Norepinephrine—Epinephrine—ADRA2C—attention deficit hyperactivity disorder	0.00044	0.0575	CrCbGaD
Norepinephrine—SLC6A2—nervous system—attention deficit hyperactivity disorder	0.00044	0.00784	CbGeAlD
Norepinephrine—SLC6A2—central nervous system—attention deficit hyperactivity disorder	0.000423	0.00755	CbGeAlD
Norepinephrine—SLC22A1—brain—attention deficit hyperactivity disorder	0.00041	0.00732	CbGeAlD
Norepinephrine—ADRA1A—nervous system—attention deficit hyperactivity disorder	0.000409	0.00729	CbGeAlD
Norepinephrine—DRD2—nervous system—attention deficit hyperactivity disorder	0.000401	0.00714	CbGeAlD
Norepinephrine—ADRB1—brain—attention deficit hyperactivity disorder	0.000395	0.00704	CbGeAlD
Norepinephrine—Methyldopa—ADRA2A—attention deficit hyperactivity disorder	0.000394	0.0515	CrCbGaD
Norepinephrine—ADRA1A—central nervous system—attention deficit hyperactivity disorder	0.000393	0.00702	CbGeAlD
Norepinephrine—SLC22A3—brain—attention deficit hyperactivity disorder	0.000392	0.00699	CbGeAlD
Norepinephrine—ADRA2C—nervous system—attention deficit hyperactivity disorder	0.000389	0.00694	CbGeAlD
Norepinephrine—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000386	0.00688	CbGeAlD
Norepinephrine—ADRA1A—cerebellum—attention deficit hyperactivity disorder	0.000385	0.00686	CbGeAlD
Norepinephrine—ADRA2A—midbrain—attention deficit hyperactivity disorder	0.000378	0.00674	CbGeAlD
Norepinephrine—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000377	0.00672	CbGeAlD
Norepinephrine—ADRA2C—central nervous system—attention deficit hyperactivity disorder	0.000375	0.00669	CbGeAlD
Norepinephrine—ADRA2C—cerebellum—attention deficit hyperactivity disorder	0.000366	0.00653	CbGeAlD
Norepinephrine—SLC22A5—cerebellum—attention deficit hyperactivity disorder	0.000351	0.00626	CbGeAlD
Norepinephrine—Levonordefrin—ADRA2A—attention deficit hyperactivity disorder	0.000349	0.0456	CrCbGaD
Norepinephrine—SLC6A2—brain—attention deficit hyperactivity disorder	0.000336	0.00599	CbGeAlD
Norepinephrine—ADRA1A—brain—attention deficit hyperactivity disorder	0.000312	0.00557	CbGeAlD
Norepinephrine—ADRA2A—nervous system—attention deficit hyperactivity disorder	0.000311	0.00554	CbGeAlD
Norepinephrine—DRD2—brain—attention deficit hyperactivity disorder	0.000306	0.00546	CbGeAlD
Norepinephrine—Dopamine—COMT—attention deficit hyperactivity disorder	0.000302	0.0395	CrCbGaD
Norepinephrine—ADRA2A—central nervous system—attention deficit hyperactivity disorder	0.000299	0.00533	CbGeAlD
Norepinephrine—ADRA2C—brain—attention deficit hyperactivity disorder	0.000298	0.00531	CbGeAlD
Norepinephrine—ADRA2A—cerebellum—attention deficit hyperactivity disorder	0.000292	0.00521	CbGeAlD
Norepinephrine—SLC22A5—brain—attention deficit hyperactivity disorder	0.000285	0.00508	CbGeAlD
Norepinephrine—L-DOPA—DRD4—attention deficit hyperactivity disorder	0.000263	0.0344	CrCbGaD
Norepinephrine—Droxidopa—ADRA2A—attention deficit hyperactivity disorder	0.000246	0.0321	CrCbGaD
Norepinephrine—Dopamine—DRD4—attention deficit hyperactivity disorder	0.000244	0.032	CrCbGaD
Norepinephrine—ADRA2A—brain—attention deficit hyperactivity disorder	0.000238	0.00424	CbGeAlD
Norepinephrine—Dopamine—MAOA—attention deficit hyperactivity disorder	0.000227	0.0298	CrCbGaD
Norepinephrine—L-DOPA—DRD3—attention deficit hyperactivity disorder	0.000227	0.0297	CrCbGaD
Norepinephrine—L-DOPA—DRD1—attention deficit hyperactivity disorder	0.000222	0.0291	CrCbGaD
Norepinephrine—Dopamine—DRD3—attention deficit hyperactivity disorder	0.000211	0.0276	CrCbGaD
Norepinephrine—Dopamine—DRD1—attention deficit hyperactivity disorder	0.000207	0.0271	CrCbGaD
Norepinephrine—Dopamine—SLC6A3—attention deficit hyperactivity disorder	0.000196	0.0257	CrCbGaD
Norepinephrine—Epinephrine—ADRA2A—attention deficit hyperactivity disorder	0.000188	0.0245	CrCbGaD
Norepinephrine—L-DOPA—DRD2—attention deficit hyperactivity disorder	0.000157	0.0205	CrCbGaD
Norepinephrine—Dopamine—SLC6A4—attention deficit hyperactivity disorder	0.000147	0.0192	CrCbGaD
Norepinephrine—Dopamine—DRD2—attention deficit hyperactivity disorder	0.000146	0.0191	CrCbGaD
Norepinephrine—ADRB1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.87e-05	0.000111	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	1.87e-05	0.00011	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	1.87e-05	0.00011	CbGpPWpGaD
Norepinephrine—DRD2—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	1.87e-05	0.00011	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.87e-05	0.00011	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	1.86e-05	0.00011	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.86e-05	0.00011	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	1.85e-05	0.000109	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	1.84e-05	0.000109	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.83e-05	0.000108	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	1.83e-05	0.000108	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	1.82e-05	0.000108	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.82e-05	0.000108	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	1.82e-05	0.000108	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.82e-05	0.000107	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	1.81e-05	0.000107	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.81e-05	0.000107	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.81e-05	0.000107	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.8e-05	0.000107	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.8e-05	0.000107	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.8e-05	0.000106	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	1.8e-05	0.000106	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.8e-05	0.000106	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.79e-05	0.000106	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.79e-05	0.000106	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	1.79e-05	0.000106	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.78e-05	0.000106	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.78e-05	0.000106	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.78e-05	0.000105	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.78e-05	0.000105	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.77e-05	0.000105	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.77e-05	0.000105	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.77e-05	0.000105	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.76e-05	0.000104	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.76e-05	0.000104	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	1.76e-05	0.000104	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.75e-05	0.000104	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.75e-05	0.000103	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.75e-05	0.000103	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.74e-05	0.000103	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	1.73e-05	0.000103	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	1.73e-05	0.000103	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.72e-05	0.000102	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.71e-05	0.000101	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	1.69e-05	0.0001	CbGpPWpGaD
Norepinephrine—PAH—Disease—EP300—attention deficit hyperactivity disorder	1.69e-05	0.0001	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	1.69e-05	9.97e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	1.68e-05	9.96e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.68e-05	9.94e-05	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	1.68e-05	9.93e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.67e-05	9.89e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	1.67e-05	9.88e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	1.67e-05	9.87e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.65e-05	9.78e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.65e-05	9.77e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.65e-05	9.76e-05	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	1.65e-05	9.76e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.65e-05	9.74e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.64e-05	9.71e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.63e-05	9.66e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	1.63e-05	9.65e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.63e-05	9.65e-05	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.63e-05	9.64e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.63e-05	9.62e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.63e-05	9.61e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	1.62e-05	9.6e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.62e-05	9.57e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	1.62e-05	9.56e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.61e-05	9.5e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.61e-05	9.49e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.59e-05	9.41e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	1.59e-05	9.4e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—TPH2—attention deficit hyperactivity disorder	1.58e-05	9.32e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.58e-05	9.32e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.57e-05	9.31e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.57e-05	9.29e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.56e-05	9.22e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	1.55e-05	9.18e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—DPYD—attention deficit hyperactivity disorder	1.55e-05	9.17e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—TPH2—attention deficit hyperactivity disorder	1.53e-05	9.07e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.53e-05	9.07e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.52e-05	9.02e-05	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—COMT—attention deficit hyperactivity disorder	1.52e-05	9e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.52e-05	8.99e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.52e-05	8.97e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	1.52e-05	8.96e-05	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—MAOA—attention deficit hyperactivity disorder	1.51e-05	8.94e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	1.51e-05	8.92e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—DPYD—attention deficit hyperactivity disorder	1.51e-05	8.92e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	1.5e-05	8.89e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.5e-05	8.86e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.5e-05	8.84e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.5e-05	8.84e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.48e-05	8.75e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.48e-05	8.74e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—TPH2—attention deficit hyperactivity disorder	1.47e-05	8.69e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.47e-05	8.69e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.47e-05	8.69e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.46e-05	8.65e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.46e-05	8.63e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.45e-05	8.57e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—DPYD—attention deficit hyperactivity disorder	1.45e-05	8.55e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.44e-05	8.54e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.44e-05	8.52e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.43e-05	8.43e-05	CbGpPWpGaD
Norepinephrine—PAH—Metabolism—EP300—attention deficit hyperactivity disorder	1.42e-05	8.38e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.41e-05	8.33e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.4e-05	8.29e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.39e-05	8.22e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.36e-05	8.07e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.36e-05	8.06e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.36e-05	8.04e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.35e-05	7.98e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.34e-05	7.95e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.33e-05	7.88e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.33e-05	7.85e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.33e-05	7.83e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.31e-05	7.73e-05	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.27e-05	7.49e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.26e-05	7.46e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.26e-05	7.46e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.26e-05	7.45e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.25e-05	7.42e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—TPH2—attention deficit hyperactivity disorder	1.25e-05	7.36e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.25e-05	7.36e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.24e-05	7.34e-05	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.24e-05	7.32e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.23e-05	7.3e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.23e-05	7.25e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—DPYD—attention deficit hyperactivity disorder	1.23e-05	7.24e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.22e-05	7.19e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.2e-05	7.09e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.19e-05	7.04e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.18e-05	6.98e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.18e-05	6.96e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.17e-05	6.95e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.17e-05	6.93e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.17e-05	6.9e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.17e-05	6.89e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.16e-05	6.84e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.15e-05	6.82e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.15e-05	6.8e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.14e-05	6.77e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.14e-05	6.77e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.14e-05	6.76e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.14e-05	6.74e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.14e-05	6.73e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.12e-05	6.65e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.12e-05	6.61e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.11e-05	6.55e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.1e-05	6.52e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.1e-05	6.52e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.1e-05	6.49e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.09e-05	6.42e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.08e-05	6.41e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.07e-05	6.34e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.06e-05	6.29e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.06e-05	6.29e-05	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.06e-05	6.29e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.06e-05	6.28e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.05e-05	6.23e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—EP300—attention deficit hyperactivity disorder	1.05e-05	6.22e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.05e-05	6.2e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.05e-05	6.19e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.04e-05	6.18e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.04e-05	6.16e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.03e-05	6.1e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.03e-05	6.1e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.02e-05	6.06e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.02e-05	6.06e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.02e-05	6.06e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.02e-05	6.02e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.01e-05	5.96e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1e-05	5.91e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	9.96e-06	5.89e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.96e-06	5.89e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.93e-06	5.87e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—EP300—attention deficit hyperactivity disorder	9.83e-06	5.81e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.77e-06	5.78e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.76e-06	5.77e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	9.7e-06	5.73e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.66e-06	5.71e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.64e-06	5.7e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.64e-06	5.7e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	9.61e-06	5.68e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.6e-06	5.68e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—COMT—attention deficit hyperactivity disorder	9.55e-06	5.65e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	9.52e-06	5.63e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	9.49e-06	5.61e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.48e-06	5.61e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—MAOA—attention deficit hyperactivity disorder	9.48e-06	5.61e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.3e-06	5.5e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.3e-06	5.5e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—COMT—attention deficit hyperactivity disorder	9.29e-06	5.49e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—MAOA—attention deficit hyperactivity disorder	9.22e-06	5.45e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.01e-06	5.33e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.98e-06	5.31e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	8.96e-06	5.3e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	8.96e-06	5.29e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—COMT—attention deficit hyperactivity disorder	8.9e-06	5.26e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.85e-06	5.23e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—MAOA—attention deficit hyperactivity disorder	8.84e-06	5.23e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.84e-06	5.22e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.74e-06	5.17e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.68e-06	5.13e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	8.65e-06	5.11e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.53e-06	5.04e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.42e-06	4.98e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	8.33e-06	4.92e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.06e-06	4.77e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—EP300—attention deficit hyperactivity disorder	7.98e-06	4.72e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.85e-06	4.64e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.83e-06	4.63e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—COMT—attention deficit hyperactivity disorder	7.55e-06	4.46e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—MAOA—attention deficit hyperactivity disorder	7.49e-06	4.43e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.46e-06	4.41e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.29e-06	4.31e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	6.88e-06	4.06e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	6.88e-06	4.06e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.79e-06	4.02e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	6.76e-06	4e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.73e-06	3.98e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.65e-06	3.93e-05	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—EP300—attention deficit hyperactivity disorder	6.53e-06	3.86e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.29e-06	3.72e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.29e-06	3.72e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.19e-06	3.66e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.06e-06	3.59e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.71e-06	3.37e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.5e-06	3.25e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.5e-06	3.25e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.23e-06	3.09e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.11e-06	3.02e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	4.17e-06	2.46e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	4.14e-06	2.45e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—EP300—attention deficit hyperactivity disorder	4.1e-06	2.42e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	4.01e-06	2.37e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—EP300—attention deficit hyperactivity disorder	3.98e-06	2.36e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.95e-06	2.34e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—EP300—attention deficit hyperactivity disorder	3.82e-06	2.26e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.6e-06	2.13e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.57e-06	2.11e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.52e-06	2.08e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.33e-06	1.97e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.28e-06	1.94e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—EP300—attention deficit hyperactivity disorder	3.24e-06	1.91e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.02e-06	1.79e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.91e-06	1.72e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.71e-06	1.6e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	1.79e-06	1.06e-05	CbGpPWpGaD
